Search results for: 'research area cell cycle plk'
-
BA9093 CWP232228Summary: CWP232228 is a potent and selective signaling pathway inhibitor in the nucleus that antagonizes binding to T cell factor (TCF). -
P1054 Neuregulin/Heregulin-1β (NRG-1β/HRG-1β), human recombinant proteinSummary: NRG-1β/HRG-1β, neurotrophin, expressed in E.Coli. -
K4005 Protease and Phosphatase Inhibitor Cocktail (EDTA plus, 100X in ddH2O)Summary: Equivalent to ThermoFisher's Halt series, inhibiting the activity of proteases and phosphatases during cell lysis and protein extraction. -
K4006 Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O)Summary: Equivalent to ThermoFisher's Halt series, inhibiting the activity of proteases and phosphatases during cell lysis and protein extraction. - BA2990 TL4-12Summary: TL4-12 is a selective inhibitor that downregulates IKZF1 and BCL-6 and inhibits MM cell proliferation (IC=37nM) and induces apoptosis.
- BA3069 NSC745885Summary: NSC745885 is a potent antitumor agent that is selectively toxic to a wide range of cancer cell lines but not to normal cells.
-
C3807 DihydroethidiumSummary: Dihydroethidium (DHE), is a peroxide indicator. It penetrates cell membranes to form fluorescent protein complexes that fluoresce blue. - BA3233 GermanicolSummary: Germanicol is a selective anti-tumor agent that inhibits the growth of human colon cancer cell lines HCT-116 and HT29.
- BA3606 STO-609Summary: STO-609 is a selective and cell permeable inhibitor with values of 80 and 15 ng/mL for recombinant CaM-KKα and CaM-KKβ, respectively.
- BA3927 TretazicarSummary: Tretazicar (CB1954) is an antitumor precursor with high potency and selectivity against the Walker256 rat tumor cell line.